stockrowCerenome, Inc. (CNSY) vs Imunon, Inc. (IMNN)
- Cerenome, Inc. CNSY 0.64 −4.48%
- Imunon, Inc. IMNN 0.85 −5.56%
Cerenome, Inc. and Imunon, Inc. are both Biotechnology companies. Cerenome, Inc. and Imunon, Inc. are of similar size ($5.1M and $5.1M). Imunon, Inc. grew revenue faster over the last twelve months: 0.00% against −21.0%. Imunon, Inc. has the higher net margin (0.00% vs −620.7%) and the higher return on invested capital (−324.4% vs −532.8%). Across the 18 metrics below, Imunon, Inc. leads on 11 and Cerenome, Inc. on 7.
Valuation
Profitability
| Metric | CNSY | IMNN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | (628.12%) | 0.00% | 0.00% |
| Net margin | (620.70%) | 0.00% | 0.00% |
| Free cash flow margin | (560.29%) | 0.00% | 0.00% |
| Return on equity | (614.05%) | (641.02%) | (51.96%) |
| Return on assets | (214.01%) | (123.93%) | (46.06%) |
| Return on invested capital | (532.77%) | (324.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack